ATARA BIOTHERAPEUTICS, INC. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $1.08 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2018-02-27
- ATARA BIOTHERAPEUTICS, INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2017 was $1.08M.
- ATARA BIOTHERAPEUTICS, INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2016 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2015 was $0.00.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month |
|---|---|
| 2017-12-31 | $1.08M 10-K · filed 2018-02-27 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-27 |
| 2015-12-31 | $0.00 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |